reference/20924481

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/20924481

Outgoing Links

Predicate	Object
contentType	Journal Article\|Research Support, U.S. Gov't, Non-P.H.S.\|Research Support, N.I.H., Extramural
endingPage	2082
issn	1538-8514 1535-7163
issueIdentifier	10
pageRange	2069-2082
publicationName	Molecular Cancer Therapeutics
startingPage	2069
hasFundingAgency	http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_b5ad88fdb9d8a30d34a9b7f844c05af4 http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_aa048e23fd0358a0129a26ab8c57f3bb http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_29d57ef5598446925e134cb5790b92ee http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_9aae042108a42b0271d810d31c1050f0 http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_cf5b9d5995507abc870f68cd20a978d7 http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_e3c18600b59b2612497bf6b95256a2d6
isSupportedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_11e6edf4bc88e76da82bbf6abdbf50c6 http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_be129e3c758ba6a9b24f7b8c41c693f9 http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_f3a6a0e3c2ca9ed63f98493d4c6b20f9 http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_b680abe2b43c467db794b810380ceb10 http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_caba18f8ec087b98fec7011781c04795 http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_3bf18fc23352d4825a9b576798156d88
bibliographicCitation	Efimenko E, Davé UP, Lebedeva IV, Shen Y, Sanchez-Quintero MJ, Diolaiti D, Kung A, Lannutti BJ, Chen J, Realubit R, Niatsetskaya Z, Ten V, Karan C, Chen X, Califano A, Diacovo TG. PI3Kγ/δ and NOTCH1 Cross-Regulate Pathways That Define the T-cell Acute Lymphoblastic Leukemia Disease Signature. Mol Cancer Ther. 2017 Oct;16(10):2069–82. PMID: 28716817; PMCID: PMC6075817.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_0fc2fa3fcfecb95443b22a6d2919f76d http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_8e7d334ae205837290436a7892a000e5 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_991b6e37d251145253d9992a5d53b03f http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_ec2fb276c0dafb8fd89fc731792f6f74 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_72e5882cb8bca531fc10da05f4db5223 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_7a10b6c6045d6b7f8dda0b3124872c20 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_08b9b01baa09d584a0b5479779de2d91 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_c91f5a671aff952da6fe5d237931743a http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_b27dc950f440f2df36073046ad6bdb21 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_04377722b69619ab144ffcce7660f6ce http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_bcefb7ebc0649ee39a3f18818d64f973 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_842b34f848f23f7515c635ccdb4a45be http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_ba00befa633044adf2b6da90abb97902 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_e95cfb0e85aeec8ad4c0a99937ac4a98 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_95dee32f926a6afe5e427fdb1fc14ed0 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_107d90d4cc6bad0d30bf1543f24a7a6b
date	2017-10-01-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier	https://pubmed.ncbi.nlm.nih.gov/PMC6075817 https://pubmed.ncbi.nlm.nih.gov/28716817 https://doi.org/10.1158/1535-7163.mct-17-0141
isPartOf	http://rdf.ncbi.nlm.nih.gov/pubchem/journal/30097 https://portal.issn.org/resource/ISSN/1538-8514 https://portal.issn.org/resource/ISSN/1535-7163
language	English
source	https://www.crossref.org/ https://pubmed.ncbi.nlm.nih.gov/
title	PI3Kγ/δ and NOTCH1 Cross-Regulate Pathways That Define the T-cell Acute Lymphoblastic Leukemia Disease Signature
discusses	http://id.nlm.nih.gov/mesh/M0024867 http://id.nlm.nih.gov/mesh/M0473380 http://id.nlm.nih.gov/mesh/M0464278 http://id.nlm.nih.gov/mesh/M0192109 http://id.nlm.nih.gov/mesh/M0469768 http://id.nlm.nih.gov/mesh/M0543149 http://id.nlm.nih.gov/mesh/M0538226 http://id.nlm.nih.gov/mesh/M0543055
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D054218Q000235 http://id.nlm.nih.gov/mesh/D058544Q000235 http://id.nlm.nih.gov/mesh/D058534Q000235 http://id.nlm.nih.gov/mesh/D051881Q000235
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D051379 http://id.nlm.nih.gov/mesh/D015398 http://id.nlm.nih.gov/mesh/D000818 http://id.nlm.nih.gov/mesh/D002471Q000235 http://id.nlm.nih.gov/mesh/D049109Q000235 http://id.nlm.nih.gov/mesh/D045744 http://id.nlm.nih.gov/mesh/D016271Q000235 http://id.nlm.nih.gov/mesh/D054218Q000473 http://id.nlm.nih.gov/mesh/D009154 http://id.nlm.nih.gov/mesh/D015973Q000235 http://id.nlm.nih.gov/mesh/D006801
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_c7be83279551b50c0e81dc2dbfe3c5d8 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID11044 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8607 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_fe0d872c4ea3e7d9f07488fc82841cc8 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_490aae5147827c2b0099b48f3f13fc2a http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_bcd6f21312d21a5cf3f0a82f59d9ac97 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID11431 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_338dc01ae46d064b5dd998a10974259a http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_472b28cee6c37ce9d58de4aa1dc6d7ef http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_d4a15b66cacf3b9e8ec302150241ecfd

Incoming Links

Predicate	Subject
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID4851 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID5294 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID5293

Total number of triples: 84.